A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

Enrolling by invitation

Conditions studied: RDEB

In brief

A Long-Term Extension Study for Participants Previously Treated with EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Key facts

Study ID

NCT05708677

Run by

Abeona Therapeutics, Inc

People needed

22

Starts

2021-02-09

Expected to finish

2036-08-01

Last updated by the study team

2026-07-17

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Willing and able to give consent/assent;
• If under the age of 18, guardian(s) is/are willing and able to give consent;
• Prior study treatment with EB-101.

You may not qualify if…

• Inability to properly follow protocol as determined by the Principal Investigator

Where it is running

• Stanford University — Redwood City, California, United States
• University of Massachusetts Medical School — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.